Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Nature Communications
|
June 28, 2020
Genetic drug target validation using Mendelian randomisation
Amand F Schmidt, Chris Finan, Maria Gordillo-Marañón, et al.
Frontiers in Genetics
|
March 8, 2021
No Clinically Relevant Effect of Heart Rate Increase and Heart Rate Recovery During Exercise on Cardiovascular Disease: A Mendelian Randomization Analysis
Josephine Mensah-Kane, Amand F Schmidt, Aroon D Hingorani, et al.
Circulation
|
March 18, 2022
Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization
Albert Henry, María Gordillo-Marañón, Chris Finan, et al.
Science Translational Medicine
|
March 31, 2017
The druggable genome and support for target identification and validation in drug development
Chris Finan, Anna Gaulton, Felix A Kruger, et al.
Scientific Reports
|
December 13, 2019
Improving the odds of drug development success through human genomics: modelling study
Aroon D Hingorani, Valerie Kuan, Chris Finan, et al.
Genes
|
November 27, 2021
The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics
Isabelle Austin-Zimmerman, Marta Wronska, Baihan Wang, et al.
Ebiomedicine
|
October 16, 2025
Integrating multi-modal omics to identify therapeutic atherosclerosis pathways for coronary heart disease
Sophie C de Ruiter, Marion van Vugt, Chris Finan, et al.
Communications Medicine
|
October 8, 2024
Disease coverage of human genome-wide association studies and pharmaceutical research and development
María Gordillo-Marañón, Amand F Schmidt, Alasdair Warwick, et al.
Communications Medicine
|
January 20, 2023
Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
Amand F Schmidt, Roshni Joshi, Maria Gordillo-Marañón, et al.
Nature Communications
|
December 17, 2020
Genetic architecture of host proteins involved in SARS-CoV-2 infection
Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Nature Communications
|
June 28, 2020
Genetic drug target validation using Mendelian randomisation
Amand F Schmidt, Chris Finan, Maria Gordillo-Marañón, et al.
Frontiers in Genetics
|
March 8, 2021
No Clinically Relevant Effect of Heart Rate Increase and Heart Rate Recovery During Exercise on Cardiovascular Disease: A Mendelian Randomization Analysis
Josephine Mensah-Kane, Amand F Schmidt, Aroon D Hingorani, et al.
Circulation
|
March 18, 2022
Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization
Albert Henry, María Gordillo-Marañón, Chris Finan, et al.
Science Translational Medicine
|
March 31, 2017
The druggable genome and support for target identification and validation in drug development
Chris Finan, Anna Gaulton, Felix A Kruger, et al.
Scientific Reports
|
December 13, 2019
Improving the odds of drug development success through human genomics: modelling study
Aroon D Hingorani, Valerie Kuan, Chris Finan, et al.
Genes
|
November 27, 2021
The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics
Isabelle Austin-Zimmerman, Marta Wronska, Baihan Wang, et al.
Ebiomedicine
|
October 16, 2025
Integrating multi-modal omics to identify therapeutic atherosclerosis pathways for coronary heart disease
Sophie C de Ruiter, Marion van Vugt, Chris Finan, et al.
Communications Medicine
|
October 8, 2024
Disease coverage of human genome-wide association studies and pharmaceutical research and development
María Gordillo-Marañón, Amand F Schmidt, Alasdair Warwick, et al.
Communications Medicine
|
January 20, 2023
Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
Amand F Schmidt, Roshni Joshi, Maria Gordillo-Marañón, et al.
Nature Communications
|
December 17, 2020
Genetic architecture of host proteins involved in SARS-CoV-2 infection
Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, et al.
Page
of 8